| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.4 | 0.0009 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.37 | 0.02 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |